SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. You have free access to this content1
    James H. Lewis, Causality assessment: Which is best—expert opinion or RUCAM?, Clinical Liver Disease, 2014, 4, 1
  2. 2
    Xiao Zhu, Naomi L. Kruhlak, Construction and analysis of a human hepatotoxicity database suitable for QSAR modeling using post-market safety data, Toxicology, 2014, 321, 62

    CrossRef

  3. 3
    W. Mattes, K. Davis, E. Fabian, J. Greenhaw, M. Herold, R. Looser, W. Mellert, S. Groeters, H. Marxfeld, N. Moeller, G. Montoya-Parra, A. Prokoudine, B. van Ravenzwaay, V. Strauss, T. Walk, H. Kamp, Detection of hepatotoxicity potential with metabolite profiling (metabolomics) of rat plasma, Toxicology Letters, 2014, 230, 3, 467

    CrossRef

  4. 4
    Sarah Tischer, Robert J. Fontana, Drug-drug interactions with oral anti-HCV agents and idiosyncratic hepatotoxicity in the liver transplant setting, Journal of Hepatology, 2014, 60, 4, 872

    CrossRef

  5. 5
    James H. Lewis, Drug-Induced Liver Injury, Dosage, and Drug Disposition: Is Idiosyncrasy Really Unpredictable?, Clinical Gastroenterology and Hepatology, 2014, 12, 9, 1556

    CrossRef

  6. 6
    Walid M Chalhoub, Kayla D Sliman, Meera Arumuganathan, James H Lewis, Drug-induced liver injury: what was new in 2013?, Expert Opinion on Drug Metabolism & Toxicology, 2014, 10, 7, 959

    CrossRef

  7. 7
    Miguel Bruguera, Envejecimiento y enfermedades del hígado, Gastroenterología y Hepatología, 2014, 37, 9, 535

    CrossRef

  8. 8
    Robert J. Fontana, Pathogenesis of Idiosyncratic Drug-Induced Liver Injury and Clinical Perspectives, Gastroenterology, 2014, 146, 4, 914

    CrossRef

  9. 9
    Minjun Chen, Halil Bisgin, Lillian Tong, Huixiao Hong, Hong Fang, Jürgen Borlak, Weida Tong, Toward predictive models for drug-induced liver injury in humans: are we there yet?, Biomarkers in Medicine, 2014, 8, 2, 201

    CrossRef

  10. 10
    Hiroshi Yamazaki, Shunji Kuribayashi, Tae Inoue, Tomohiro Honda, Chise Tateno, Ken Oofusa, Shinichi Ninomiya, Toshihiko Ikeda, Takashi Izumi, Toru Horie, Zone analysis by two-dimensional electrophoresis with accelerator mass spectrometry of in vivo protein bindings of idiosyncratic hepatotoxicants troglitazone and flutamide bioactivated in chimeric mice with humanized liver, Toxicol. Res., 2014, 4, 1, 106

    CrossRef

  11. 11
    James H. Lewis, Drug-Induced Liver Injury Throughout the Drug Development Life Cycle: Where We Have Been, Where We are Now, and Where We are Headed. Perspectives of a Clinical Hepatologist, Pharmaceutical Medicine, 2013, 27, 3, 165

    CrossRef